a Q<sup>2</sup> Solutions Company

Just type and press 'enter'

Toggle menu

About Us
- About RBM
  Rules-Based Medicine (RBM), a Q² Solutions Company, is a CLIA certified, multiplexed immunoassay testing laboratory that solves complex drug development challenges with innovative biomarker services.
- About RBM
- Newsroom
- Data Quality
  - Overview
  - RBM Technology
Biomarker Solutions
- Solutions
  - Overview
  - Assay Change Log
  If a smaller, more focused panel of analytes is required, we can build a Custom MAP to meet your needs.
  
  Learn More »
- Multiplexed Immunoassays
- Whole Blood Collection and Culture System
  Learn More »
  
  Ultrasensitive immunoassays manufactured by RBM and based on Quanterix’s Simoa technology.
  Learn More »
Resources + Support
- Resources
- Support
How to Order
- Ordering Information
- Request Information
- Ready to Order?
  
  Great!
  
  Every order starts with a quote.
  
  Get Started

Category Archives: Blog

14 Mar 2011

Colorectal Cancer Metastases Prognostic Biomarker Identified

March 14, 2011

Desiree Klingler-Gaston

Blog, Cancer

This week's paper was recently published in PLoS One as the researchers sought prognostic biomarkers for colorectal cancer metastases (CLM). Colorecta...

1 … 18 19 20